Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Safer

Showing results (61-70 of 107) with videos related to

Pageof 11
Sort By:
The American Journal of Psychiatry|April 1, 1979
Multiple ECT: morphologic effectsM Menken, J Safer, C Goldfarb, et al.
Pharmacoepidemiology and Drug Safety|October 29, 2015
Antipsychotic prescribing for behavioral disorders in US youth: physician specialty, insurance coverage, and complex regimensMehmet Burcu, Daniel J Safer, Julie M Zito
Frontiers in Psychiatry|April 2, 2020
Antidepressant Use in Medicaid-Insured Youth: Trends, Covariates, and Future Research NeedsJulie M Zito, Dinci Pennap, Daniel J Safer
The Journal of Pediatrics|January 1, 1975
Growth rebound after termination of stimulant drugsD J Safer, R P Allen, E Barr
Frontiers in Psychiatry|July 1, 2021
Psychotropic Polypharmacy in the US Pediatric Population: A Methodologic Critique and CommentaryJulie M Zito, Yue Zhu, Daniel J Safer
Pediatrics|December 1, 1996
Increased methylphenidate usage for attention deficit disorder in the 1990sD J Safer, J M Zito, E M Fine
Psychiatric Services (Washington, D.C.)|September 4, 2004
Comparative prevalence of psychotropic medications among youths enrolled in the SCHIP and privately insured youthsDaniel J Safer, Julie Magno Zito, James F Gardner
Comprehensive Psychiatry|June 12, 2012
Age-grouped differences in bipolar maniaDaniel J Safer, Julie Magno Zito, Alan M Safer
Journal of the American Academy of Child and Adolescent Psychiatry|June 8, 2001
Pemoline hepatotoxicity and postmarketing surveillanceD J Safer, J M Zito, J E Gardner
Journal of Child and Adolescent Psychopharmacology|May 8, 2013
Prolactin serum concentrations during aripiprazole treatment in youthDaniel J Safer, Chadi A Calarge, Alan M Safer
Pageof 11

Showing results (61-70 of 107) with videos related to

Sort By:
Pageof 11
The American Journal of Psychiatry|April 1, 1979
Multiple ECT: morphologic effectsM Menken, J Safer, C Goldfarb, et al.
Pharmacoepidemiology and Drug Safety|October 29, 2015
Antipsychotic prescribing for behavioral disorders in US youth: physician specialty, insurance coverage, and complex regimensMehmet Burcu, Daniel J Safer, Julie M Zito
Frontiers in Psychiatry|April 2, 2020
Antidepressant Use in Medicaid-Insured Youth: Trends, Covariates, and Future Research NeedsJulie M Zito, Dinci Pennap, Daniel J Safer
The Journal of Pediatrics|January 1, 1975
Growth rebound after termination of stimulant drugsD J Safer, R P Allen, E Barr
Frontiers in Psychiatry|July 1, 2021
Psychotropic Polypharmacy in the US Pediatric Population: A Methodologic Critique and CommentaryJulie M Zito, Yue Zhu, Daniel J Safer
Pediatrics|December 1, 1996
Increased methylphenidate usage for attention deficit disorder in the 1990sD J Safer, J M Zito, E M Fine
Psychiatric Services (Washington, D.C.)|September 4, 2004
Comparative prevalence of psychotropic medications among youths enrolled in the SCHIP and privately insured youthsDaniel J Safer, Julie Magno Zito, James F Gardner
Comprehensive Psychiatry|June 12, 2012
Age-grouped differences in bipolar maniaDaniel J Safer, Julie Magno Zito, Alan M Safer
Journal of the American Academy of Child and Adolescent Psychiatry|June 8, 2001
Pemoline hepatotoxicity and postmarketing surveillanceD J Safer, J M Zito, J E Gardner
Journal of Child and Adolescent Psychopharmacology|May 8, 2013
Prolactin serum concentrations during aripiprazole treatment in youthDaniel J Safer, Chadi A Calarge, Alan M Safer
Pageof 11